See the DrugPatentWatch profile for Alphagan
The price of Alphagan P can vary depending on factors such as location, pharmacy, and insurance coverage.
What is Alphagan P?
Alphagan P is a brand-name prescription eye drop used to treat glaucoma and ocular hypertension. Its active ingredient is brimonidine tartrate [1]. Brimonidine tartrate is an alpha-adrenergic agonist that works by decreasing the amount of fluid in the eye, thereby lowering intraocular pressure (IOP) [2].
How much does Alphagan P typically cost?
The retail price for a 30-day supply of 0.15% Alphagan P eye drops is approximately $300 to $400 without insurance. The exact cost can fluctuate. For instance, a 5 mL bottle of Alphagan P (0.15%) may cost around $350 at some pharmacies [3].
Can I get financial assistance for Alphagan P?
For individuals without insurance or those with high co-pays, financial assistance programs may be available. Manufacturers often offer savings cards or co-pay assistance programs that can reduce out-of-pocket costs [4]. Checking the official Alphagan P website or consulting with a pharmacist can provide information on current savings programs.
What is the generic version of Alphagan P and its price?
The generic version of Alphagan P is brimonidine tartrate ophthalmic solution 0.15%. Generic medications are typically less expensive than their brand-name counterparts. The price for generic brimonidine tartrate eye drops can range from $20 to $50 for a 30-day supply, depending on the pharmacy and insurance plan [3].
When does the patent for Alphagan P expire?
Drug patent information, including expiry dates, can be complex and is subject to various legal challenges and extensions. Information on the specific patent status and expiry dates for Alphagan P can be found on resources like DrugPatentWatch.com [5].
How does Alphagan P compare to other glaucoma medications?
Alphagan P is one of several medications used to manage glaucoma. Other classes of drugs include prostaglandin analogs (like latanoprost), beta-blockers (like timolol), and carbonic anhydrase inhibitors (like dorzolamide). The choice of medication depends on the individual patient's condition, response to treatment, and potential side effects [6]. Each medication has its own pricing structure and availability of generic options.
Sources:
[1] https://www.drugs.com/alphagan.html
[2] https://www.webmd.com/drugs/2/204746/alphagan-p-ophthalmic-drops/details
[3] https://www.goodrx.com/alphagan-p
[4] https://www.rxhope.com/patient-assistance-programs
[5] https://drugpatentwatch.com/
[6] https://www.mayoclinic.org/diseases-conditions/glaucoma/diagnosis-treatment/drc-20372845